DALE N WHEELAND
Allopathic & Osteopathic Physicians|Family Medicine TUCSON, AZ NPI 1669488573
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine AZ Janssen Pharmaceuticals, Inc All categories
General Payments — all program years on this page
$1,349.66
- Category: General Payments
- Program years: PY2018–2024
- Record count: 57
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $376.00 across 9 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $376.00 | 9 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $169.03 | 2 |
| Lilly USA, LLC | $102.22 | 1 |
| EISAI INC. | $72.68 | 4 |
| Acerta Pharma LLC | $32.07 | 2 |
By program year
Records — PY2024 (9)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1077917025 | Janssen Pharmaceuticals, Inc | $23.88 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1077917245 | Janssen Pharmaceuticals, Inc | $145.15 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104379951 | AstraZeneca Pharmaceuticals LP | $17.55 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1105777250 | AstraZeneca Pharmaceuticals LP | $14.52 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110738105 | Eisai Inc. | $19.35 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110738107 | Eisai Inc. | $20.76 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110738109 | Eisai Inc. | $14.72 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1110738111 | Eisai Inc. | $17.85 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1136115610 | Lilly USA, LLC | $102.22 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.